These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

255 related items for PubMed ID: 7176819

  • 1. Scopolamine self-administration: cholinergic involvement in reward mechanisms.
    Glick SD, Guido RA.
    Life Sci; 1982 Aug 30; 31(9):909-13. PubMed ID: 7176819
    [Abstract] [Full Text] [Related]

  • 2. Central muscarinic receptors and male rat sexual behavior: facilitation by oxotremorine but not arecoline or pilocarpine in methscopolamine pretreated animals.
    Ahlenius S, Larsson K.
    Psychopharmacology (Berl); 1985 Aug 30; 87(2):127-9. PubMed ID: 3931135
    [Abstract] [Full Text] [Related]

  • 3. Interactions between scopolamine and muscarinic cholinergic agonists or cholinesterase inhibitors on spatial alternation performance in rats.
    Shannon HE, Bemis KG, Hendrix JC, Ward JS.
    J Pharmacol Exp Ther; 1990 Dec 30; 255(3):1071-7. PubMed ID: 2262893
    [Abstract] [Full Text] [Related]

  • 4. Cholinergic modulation of oral activity in drug-naive and chronic haloperidol-treated rats.
    See RE, Chapman MA.
    Pharmacol Biochem Behav; 1991 May 30; 39(1):49-54. PubMed ID: 1924511
    [Abstract] [Full Text] [Related]

  • 5. Cholinergic effects on spatial exploration and its memory.
    Kelly PH, Malanowski J.
    Can J Physiol Pharmacol; 1993 May 30; 71(5-6):352-64. PubMed ID: 8402401
    [Abstract] [Full Text] [Related]

  • 6. Effects of muscarinic receptor agonists and antagonists on alpha 2-adrenoceptors in rat brain.
    Hollingsworth PJ, Smith CB.
    Eur J Pharmacol; 1989 Sep 13; 168(2):159-67. PubMed ID: 2558024
    [Abstract] [Full Text] [Related]

  • 7. Characteristics of yawning behavior induced by apomorphine, physostigmine and pilocarpine.
    Ushijima I, Mizuki Y, Imaizumi J, Yamada M, Noda Y, Yamada K, Furukawa T.
    Arch Int Pharmacodyn Ther; 1985 Feb 13; 273(2):196-201. PubMed ID: 4004417
    [Abstract] [Full Text] [Related]

  • 8. Discriminative stimulus properties of physostigmine in rats.
    Tang AH, Franklin SR.
    Eur J Pharmacol; 1988 Aug 09; 153(1):97-104. PubMed ID: 3215280
    [Abstract] [Full Text] [Related]

  • 9. Cholinergic drug effects on a delayed conditional discrimination task in the rat.
    Herremans AH, Hijzen TH, Olivier B, Slangen JL.
    Behav Neurosci; 1995 Jun 09; 109(3):426-35. PubMed ID: 7662153
    [Abstract] [Full Text] [Related]

  • 10. Anti-muscarinic drug effects in a swim-to-platform test: dose-response relations.
    Vanderwolf CH.
    Behav Brain Res; 1991 Aug 29; 44(2):217-9. PubMed ID: 1751013
    [Abstract] [Full Text] [Related]

  • 11. Effects of cholinergic agonists on the dorsal immobility response.
    Potter TJ, Cottrell GA, Van Hartesveldt C.
    Pharmacol Biochem Behav; 1990 May 29; 36(1):77-80. PubMed ID: 2349272
    [Abstract] [Full Text] [Related]

  • 12. Discriminative stimulus properties of muscarinic agonists.
    Jung M, Costa L, Shearman GT, Kelly PH.
    Psychopharmacology (Berl); 1987 May 29; 93(2):139-45. PubMed ID: 3122245
    [Abstract] [Full Text] [Related]

  • 13. Differential response to cholinergic stimulation in psychogenitically selected rat lines.
    Martin JR, Driscoll P, Gentsch C.
    Psychopharmacology (Berl); 1984 May 29; 83(3):262-7. PubMed ID: 6433388
    [Abstract] [Full Text] [Related]

  • 14. Cholinergic modulation of spatial learning in mice in a Morris-type water maze.
    Lamberty Y, Gower AJ.
    Arch Int Pharmacodyn Ther; 1991 May 29; 309():5-19. PubMed ID: 1888229
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Effects of cholinergic drugs on prey-killing by rodents.
    Wnek DJ, Leaf RC.
    Physiol Behav; 1973 Jun 29; 10(6):1107-13. PubMed ID: 4736903
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Neuroleptic-induced emotional defecation: effects of scopolamine and haloperidol.
    Sanberg PR, Russell KH, Hagenmeyer-Houser SH, Giordano M, Zubrycki EM, Garver DL.
    Psychopharmacology (Berl); 1989 Jun 29; 99(1):60-3. PubMed ID: 2506605
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Modulation of the aversive qualities of shock through a central inhibitory cholinergic system in the rat.
    Houser VP.
    Pharmacol Biochem Behav; 1976 May 29; 4(5):561-8. PubMed ID: 951435
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.